These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9820506)

  • 41. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.
    Taylor PA; Noelle RJ; Blazar BR
    J Exp Med; 2001 Jun; 193(11):1311-8. PubMed ID: 11390438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Operational tolerance induced by pretreatment with donor dendritic cells under blockade of CD40 pathway.
    Niimi M; Shirasugi N; Ikeda Y; Kan S; Takami H; Hamano K
    Transplantation; 2001 Nov; 72(9):1556-62. PubMed ID: 11707745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice.
    Li ZL; Xue WJ; Tian PX; Ding XM; Tian XH; Feng XS; Hou J
    Transplant Proc; 2007 Dec; 39(10):3436-7. PubMed ID: 18089400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prolonged allograft survival following ex vivo blockade of costimulatory signals B7-1/2 and CD40.
    Steurer W; Oellinger R; Perwanger F; Brandacher G; Obrist P; Klima G; Margreiter R
    Transplant Proc; 2001; 33(1-2):274-5. PubMed ID: 11266816
    [No Abstract]   [Full Text] [Related]  

  • 45. CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.
    Blazar BR; Taylor PA; Noelle RJ; Vallera DA
    J Clin Invest; 1998 Aug; 102(3):473-82. PubMed ID: 9691083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.
    Jones ND; Van Maurik A; Hara M; Spriewald BM; Witzke O; Morris PJ; Wood KJ
    J Immunol; 2000 Jul; 165(2):1111-8. PubMed ID: 10878390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.
    Holländer GA; Castigli E; Kulbacki R; Su M; Burakoff SJ; Gutierrez-Ramos JC; Geha RS
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4994-8. PubMed ID: 8643517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A self-immunomodulating myoblast cell line for erythropoietin delivery.
    Schneider BL; Peduto G; Aebischer P
    Gene Ther; 2001 Jan; 8(1):58-66. PubMed ID: 11402302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD40-ligand in primate cardiac allograft and viral immunity.
    Pierson RN; Crowe JE; Pfeiffer S; Atkinson J; Azimzadeh A; Miller GG
    Immunol Res; 2001; 23(2-3):253-62. PubMed ID: 11444390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.
    Pollak R; Blanchard JM
    Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
    Saitovitch D; Morris PJ; Wood KJ
    Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
    Sun H; Subbotin V; Chen C; Aitouche A; Valdivia LA; Sayegh MH; Linsley PS; Fung JJ; Starzl TE; Rao AS
    Transplantation; 1997 Dec; 64(12):1838-43. PubMed ID: 9422428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade.
    Coenen JJ; Koenen HJ; van Rijssen E; Boon L; Joosten I; Hilbrands LB
    J Immunol; 2006 May; 176(9):5240-6. PubMed ID: 16621989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
    Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
    Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.
    Smyth LA; Ratnasothy K; Moreau A; Alcock S; Sagoo P; Meader L; Tanriver Y; Buckland M; Lechler R; Lombardi G
    J Immunol; 2013 May; 190(9):4848-60. PubMed ID: 23536635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.
    Burrell BE; Lu G; Li XC; Bishop DK
    J Immunol; 2009 Jan; 182(1):379-90. PubMed ID: 19109169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. B7-2+ low density APCS are as effective as B7-2- small resting B cells in inducing specific unresponsiveness to minor histocompatibility (miH) antigen(s) in vivo.
    Niimi M; Rawsthorne MA; Morris PJ; Wood KJ
    Adv Exp Med Biol; 1997; 417():265-8. PubMed ID: 9286371
    [No Abstract]   [Full Text] [Related]  

  • 58. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.
    Honey K; Cobbold SP; Waldmann H
    J Immunol; 1999 Nov; 163(9):4805-10. PubMed ID: 10528180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
    Burns AM; Ma L; Li Y; Yin D; Shen J; Xu J; Chong AS
    J Immunol; 2009 Feb; 182(3):1314-24. PubMed ID: 19155477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade.
    Elwood ET; Larsen CP; Cho HR; Corbascio M; Ritchie SC; Alexander DZ; Tucker-Burden C; Linsley PS; Aruffo A; Hollenbaugh D; Winn KJ; Pearson TC
    Transplantation; 1998 Jun; 65(11):1422-8. PubMed ID: 9645796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.